Lucentis Archives -

FDA OKs first biosimilar of Roche’s blockbuster AMD drug Lucentis

https://pharmaphorum.com/news/fda-oks-first-biosimilar-of-roches-blockbuster-amd-drug-lucentis/

Europe has its first Lucentis biosimilar, Samsung Bioepis’ Byooviz

https://pharmaphorum.com/news/europe-has-its-first-lucentis-biosimilar-samsung-bioepis-byooviz/

Novartis says trials back Beovu safety in diabetic eye disease

https://pharmaphorum.com/news/novartis-says-trials-back-beovu-safety-in-diabetic-eye-disease/

Roche eyes October decision by FDA for wet AMD implant

https://pharmaphorum.com/news/roche-eyes-october-decision-by-fda-for-wet-amd-implant/

Novartis taps smartpatient for app to support wet AMD patients

https://pharmaphorum.com/news/novartis-taps-smartpatient-for-app-to-support-wet-amd-patients/

Novartis’ blockbuster hope Beovu clears EMA advisory panel

https://pharmaphorum.com/news/novartis-blockbuster-hope-beovu-clears-ema-advisory-panel/

MHRA says Avastin can be used for AMD despite Bayer, Novartis objections

https://pharmaphorum.com/news/mhra-says-avastin-can-be-used-for-amd-despite-bayer-novartis-objections/

Novartis backs brolucizumab with new head-to-head Eylea trial

https://pharmaphorum.com/news/novartis-backs-brolucizumab-with-new-head-to-head-eylea-trial/

Novartis to buy ophthalmology firm Encore Vision

https://pharmaphorum.com/news/novartis-buy-ophthalmology-firm-encore-vision/

Search